MedPath

Efficacy of ipragliflozin on glucose metabolism

Not Applicable
Conditions
type 2 diabetes mellitus
Registration Number
JPRN-UMIN000013921
Lead Sponsor
Shiraiwa Medical Clinic
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

- severe hepatic, renal, and/or cardiac diseae - contraindication to ipragliflozin - pregnant or breast-feeding females

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath